ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Clinic Experiment Pathol 2012, Vol 2(4): 113
  • DOI: 10.4172/2161-0681.1000113

Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML)

Zeba Singh1*, Stephen Medlin2 and Saad Z Usmani2
1Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
2Myeloma Institute for Research & Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA
*Corresponding Author : Zeba Singh, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Mail Slot 502 Little Rock, AR 72205, USA, Email: zsingh@uams.edu

Received Date: May 09, 2012 / Accepted Date: Jun 14, 2012 / Published Date: Jun 17, 2012

Keywords: CML; Targeted therapy; Tyrosine kinase inhibitors; Drug resistance; Molecular monitoring

Citation: Singh Z, Medlin S, Usmani SZ (2012) Molecular Monitoring and Treatment of Chronic Myeloid Leukemia (CML). J Clin Exp Pathol 2:113. Doi: 10.4172/2161-0681.1000113

Copyright: © 2012 Singh Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top